Article Information
History
- February 1, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Nicolas Waespe, MD1,2,3,
- Sven Strebel, MSc Pharm1,2,4,
- Tiago Nava, MD2,5,
- Chakradhara Rao S. Uppugunduri, PhD Pharm2,
- Denis Marino, MSc2,
- Veneranda Mattiello, MD2,5,
- Maria Otth, MD1,3,6,
- Fabienne Gumy-Pause, MD2,5,
- André O. von Bueren, MD, PhD2,5,
- Frederic Baleydier, MD, PhD2,5,
- Luzius Mader, PhD1,
- Adrian Spoerri, PhD, MPH8,
- Claudia E. Kuehni, MD, MSc1,7 and
- Marc Ansari, MD2,5,*
- 1Childhood Cancer Research Group, Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland
- 2Research Platform for Pediatric Oncology and Hematology (CANSEARCH Research Platform), Department of Pediatrics, Gynecology, and Obstetrics, University of Geneva, Geneva, Switzerland
- 3Graduate School for Cellular and Biomedical Sciences (GCB), University of Bern, Bern, Switzerland
- 4Graduate School for Health Sciences (GHS), University of Bern, Bern, Switzerland
- 5Division of Pediatric Oncology and Hematology, Department of Women, Children, and Adolescents, University Hospital of Geneva, Geneva, Switzerland
- 6Division of Oncology-Hematology, Department of Pediatrics, Kantonsspital Aarau AG, Aarau, Switzerland
- 7Division of Pediatric Oncology and Hematology, Department of Pediatrics, University Hospital of Bern, Bern, Switzerland
- 8SwissRDL - Medical Registries and Data Linkage, Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland
- ↵*Corresponding author:
Prof. Dr. med. Marc Ansari, MD; Division of Pediatric Oncology and Hematology, Department of Women, Children, and Adolescents, University Hospital of Geneva, Rue Willy-Donzé 6; Bureau 5-507; 1211 Genève, Switzerland; T: +41 22 372 47 31; F : +41 22 382 31 00, E-mail : marc.ansari{at}hcuge.ch
Posted February 01, 2021.
Cohort-based association study of germline genetic variants with acute and chronic health complications of childhood cancer and its treatment: Genetic risks for childhood cancer complications Switzerland (GECCOS) study protocol
